Back

Atrial fibrillation ablation as first line treatment in persistent atrial fibrillation - rebuttal & discussion

25 April 2021 (10:51 - 11:03)
Organised by:
Congress Presentation Part of: Controversies in rhythm control therapy in persistent atrial fibrillation and obesity Lifestyle Modification EHRA Premium Access EHRA 2021

5 More presentations in this session

Presentation thumbnail
Atrial fibrillation ablation as first line treatment in persistent atrial fibrillation - pro
Professor L. Di Biase (The Bronx, US)
Video
Presentation thumbnail
Atrial fibrillation ablation as first line treatment in persistent atrial fibrillation - con
Professor I. Van Gelder (Groningen, NL)
Slides Video
Presentation thumbnail
Weight loss before ablation of an obese patient - pro
Professor P. Sanders (Adelaide, AU)
Slides Video
Presentation thumbnail
Weight loss before ablation of an obese patient - con
Doctor B. Schmidt (Frankfurt, DE)
Slides Video
Presentation thumbnail
Weight loss before ablation of an obese patient - rebuttal & discussion

Access the full session

Session thumbnail
Controversies in rhythm control therapy in persistent atrial fibrillation and obesity

The Event

Event poster

EHRA 2021

25 April 2021 10:51 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources